Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2016

May 14, 2016

30643_dirs_2016-05-13_8de34505-6d84-4c91-b128-314d0b885953.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-05-12

Reporting Person: Valine Roger (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-12 Common Stock M 18000 $41.465 Acquired 18324 Direct
2016-05-12 Common Stock F 9780 $76.32 Disposed 8544 Direct
2016-05-12 Common Stock S 8220 $76.3423 Disposed 324 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-12 Stock Appreciation Rights $41.465 M 18000 Disposed 2016-06-06 Common Stock (18000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 18104 Indirect

Footnotes

F1: Represents the weighted average sale price of $76.3423. The range of prices for the sale of these shares was $76.16-$76.50 rounded to the nearest hundredth. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: The Stock Appreciation Rights were granted on 6/6/2011, and became fully vested on 6/6/2012.